Variant report
Variant | nsv969483 |
---|---|
Chromosome Location | chr6:65964257-65990271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143863403 | chr6:65969033-65969034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574365337 | chr6:65969048-65969049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543365448 | chr6:65969062-65969063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190600831 | chr6:65969087-65969088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35799825 | chr6:65969103-65969104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181687146 | chr6:65969111-65969112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576864238 | chr6:65969117-65969118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542249813 | chr6:65969183-65969184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148618496 | chr6:65969193-65969194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569159400 | chr6:65969228-65969229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536372 | chr6:65969239-65969240 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs371043867 | chr6:65969261-65969262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528245602 | chr6:65969297-65969298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551596885 | chr6:65969307-65969308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369958243 | chr6:65969329-65969330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572771528 | chr6:65969337-65969338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187130613 | chr6:65969345-65969346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115918586 | chr6:65969376-65969377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530811855 | chr6:65969449-65969450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74797972 | chr6:65969460-65969461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370238828 | chr6:65969465-65969466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373463683 | chr6:65969523-65969524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148636102 | chr6:65969533-65969534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368529833 | chr6:65969603-65969604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115445599 | chr6:65969621-65969622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs697304 | chr6:65969644-65969645 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs73443111 | chr6:65969661-65969662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534329553 | chr6:65969668-65969669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12212937 | chr6:65969675-65969676 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs77317736 | chr6:65969728-65969729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569531427 | chr6:65969739-65969740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536688919 | chr6:65969740-65969741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544045479 | chr6:65969815-65969816 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72883272 | chr6:65969854-65969855 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs182451362 | chr6:65969855-65969856 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73741283 | chr6:65969870-65969871 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146165118 | chr6:65969886-65969887 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140185554 | chr6:65969904-65969905 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187869406 | chr6:65969963-65969964 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189940294 | chr6:65969979-65969980 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182484276 | chr6:65969993-65969994 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544312134 | chr6:65969999-65970000 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552891336 | chr6:65970029-65970030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143752370 | chr6:65970035-65970036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533335775 | chr6:65970078-65970079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs151305903 | chr6:65970084-65970085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs377537683 | chr6:65970085-65970086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572963810 | chr6:65970094-65970095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140480632 | chr6:65970105-65970106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549546148 | chr6:65970137-65970138 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65969000-65969800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:65969200-65969400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:65969200-65970600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr6:65969400-65970400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:65969400-65970800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:65969600-65969800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr6:65969600-65970400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr6:65969600-65971000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr6:65969800-65970000 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
10 | chr6:65970000-65970400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr6:65970000-65970400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr6:65970800-65971800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |